Capital Raising & Corporate Finance
Fintech To Disrupt Israel’s Banks
One Zero stands out as an exclusively digital but nonetheless fully licensed bank.
Author: Efraim Chalamish
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Capital Raising & Corporate Finance
The Backlash Against SPACs Has Begun As Lawsuits Pile Up
More than two dozen shareholder class actions were filed with New York and Delaware courts in the past two years.
News
Tech Companies Entertain Different Talent Incentives
The fast-rising valuations of tech companies have also motivated firms to change their employeeincentive structures.
Capital Raising & Corporate Finance
Tight Talent Market Forces Innovation
New technologies demand new kinds of talent and make addressing labor shortages easier.
Capital Raising & Corporate Finance
SPAC Deals Spark Boom In Fairness Opinions
One trend driving the recent rise in fairness advisories is the SPAC wave.
Capital Raising & Corporate Finance
SPACs Catch On Outside US
Special-purpose acquisition companies are going global.
Capital Raising & Corporate Finance
New Tariffs And Social Media Drive Trade Strategy
These are not your grandfather's trade wars.
Features
Finance For A Future: Q&A With DC Green Bank’s Jay Lurie
Jay Lurie, currently chief investment officer of DC Green Bank, has more than a decade in financing and infrastructure development worldwide in positions at Macquarie, Credit Suisse, and the World Bank Group’s International Finance Corporation (IFC). He talks with Global Finance about climate change and the finance sector.
Capital Raising & Corporate Finance
NYSE Big Board Blocks Chinese Stocks
The delisting follows a series of executive orders targeting Chinese technology companies as national security risks.
Capital Raising & Corporate Finance
New Tech Listings Roll On
The world economy may be down but IPOs are up.
Features
Funding A Solution: aMoon Managing Director Dr. Gur Roshwalb Q&A
Dr. Gur Roshwalb, a former medical practitioner and now managing director at aMoon, a health technology and life sciences venture fund, discusses how Covid-19 is changing biotech investing, what he looks for as an investor and which new sectors are gaining momentum.
News
Infrastructure Assets Go To Global Markets
The infrastructure financing challenge has spurred innovative capital market solutions and public financial tools.